Lung immune cells help heal lung tissue after severe injury
Lung leukocytes promote alveolar epithelial regeneration after severe injury
This study is looking at how certain immune cells in your lungs help heal after serious injuries, like those from infections, and it hopes to find new ways to improve lung recovery for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10828445 on NIH RePORTER |
What this research studies
This research investigates how specific immune cells in the lungs, particularly regulatory T cells, contribute to the healing process after severe lung injuries. By examining the interactions between these immune cells and lung epithelial cells, the study aims to understand how they promote tissue repair and maintain lung function. The approach involves analyzing the production of growth factors that aid in the regeneration of lung tissue following damage from various causes, including infections. Patients may benefit from insights gained into new therapeutic strategies for enhancing lung repair.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced severe lung injuries or conditions that impair lung function.
Not a fit: Patients with chronic lung diseases that do not involve acute injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve recovery from severe lung injuries.
How similar studies have performed: Other research has shown promising results in understanding the role of immune cells in tissue repair, suggesting that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Arpaia, Nicholas — Columbia University Health Sciences
- Study coordinator: Arpaia, Nicholas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.